Mount Sinai Hospital
The Mount Sinai Health System is proud to be home to the first MRI-Guided TULSA (Transurethral Ultrasound Ablation) Program in New York City, bringing patients a transformative, incision-free treatment option for prostate cancer and benign prostatic hyperplasia.
As one of the nation’s leading academic medical centers, Mount Sinai combines world-class radiology and urology expertise to offer a comprehensive, multidisciplinary approach to prostate care. The TULSA program integrates state-of-the-art MRI technology with real-time thermal ablation, allowing physicians to precisely target and destroy cancerous or enlarged prostate tissue while preserving surrounding structures—minimizing side effects and promoting faster recovery.
The program is led by a collaborative team of radiologists and urologists recognized nationally for their innovation in prostate imaging, robotic and image-guided surgery, and minimally invasive therapy. Their expertise, coupled with Mount Sinai’s advanced imaging infrastructure and commitment to research, positions the institution at the forefront of next-generation men’s health treatment.
Through the TULSA program, Mount Sinai is expanding access to cutting-edge prostate therapy—delivering personalized, patient-centered care that emphasizes precision, safety, and quality of life.
Have questions? We're here to help.
If you have questions about the TULSA Procedure, connect with one of our helpful Patient Educators.
Center Address
1000 10th Avenue, New York, NY, USA
Appointments
When prompted, press 2.
At the next menu, press 1 to reach the Interventional Radiology Department / TULSA Program.
